𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

✍ Scribed by Ross, Colin J D; Katzov-Eckert, Hagit; Dubé, Marie-Pierre; Brooks, Beth; Rassekh, S Rod; Barhdadi, Amina; Feroz-Zada, Yassamin; Visscher, Henk; Brown, Andrew M K; Rieder, Michael J


Book ID
109914533
Publisher
Nature Publishing Group
Year
2009
Tongue
English
Weight
334 KB
Volume
41
Category
Article
ISSN
1061-4036

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Hearing loss in children with brain tumo
✍ Freilich, Ronnie J.; Kraus, Dennis H.; Budnick, Amy S.; Bayer, Lisa A.; Finlay, 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 602 KB

Carboplatin is less ototoxic than cisplatin, but ototoxicity may occur with carboplatin at higher doses. We evaluated hearing in children with brain tumors treated with conventional dose cisplatin followed by highdose carboplatin. Children under 6 years of age, newly diagnosed with brain tumors, wer